Institutional Biosafety Committee

Similar documents
Institutional Biosafety Committee

ENVIRONMENT, HEALTH AND SAFETY POLICY

Psychology Animal Facility Handbook

Model Infection Control Plan for Veterinary Practices, 2010

Animal Dairy Science Facility Handbook

Model Infection Control Plan for Veterinary Practices, 2015

Standard Operating Procedure 1.01 General Policies and Procedures for Animal Users at the Mouse Phenotyping, Physiology and Metabolic Core

Biological Sciences Animal Facility Handbook

Preparing for an AAALAC (and IACUC) Site Visit

GENERAL PREVENTION PRACTICES CHECKLIST FOR SHEEP AND GOAT PRODUCERS

Cal Poly Animal Handler Occupational Health & Safety Program

Shelter Operations /13/2015

GENERAL PREVENTION PRACTICES CHECKLIST FOR BEEF AND DAIRY PRODUCERS

Event Biosecurity Worksheet

SECTION 1: CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

DEPARTMENT OF LABOR AND INDUSTRIES Division of Occupational Safety and Health PO Box Olympia, Washington

Material Safety Data Sheet

CHAPTER 44 - ZOONOSES CONTROL

UNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee

FLORIDA ATLANTIC UNIVERSITY

EASTER BUSH PATHOLOGY, R(D)SVS POST MORTEM ROOM CODE OF PRACTICE CONTENTS

General Prevention Practices for Beef and dairy Producers

LUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification MADE IN INDIA

Procedure Number: AH Cage Cards 007 Revision Number: 3 Effective Date: May 2013 Expiration Date: November Purpose

GENERAL PREVENTION PRACTICES CHECKLIST FOR SWINE PRODUCERS

To describe step-wise procedures for the collection of live fleas from prairie dog burrows.

SECTION 1: CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT SAFETY DATA SHEET OF FIPRONIL 0.05% GEL

EASTER BUSH PATHOLOGY, R(D)SVS POST MORTEM ROOM CODE OF PRACTICE CONTENTS

Service Dogs in the Chemistry Laboratory: Some Considerations

Using Animals in Research at PSU

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA

Date in effect: 3/7/2016. Page: 1 of 7

Baytril 10% Injectable solution Enrofloxacin 10% Injection Antibacterial treatment for cats and dogs. RESTRICTED VETERINARY MEDICINE

Visitors Animal Safety Awareness

SURGICAL (SURVIVAL) OOCYTE COLLECTION FROM XENOUS LAEVIS

For the control of FERAL PIGEONS IN, ON OR IN THE AREA OF STRUCTURES, NESTING AND ROOSTING SITES REGISTRATION NO PEST CONTROL PRODUCTS ACT

Clinic Infectious Disease Control

STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA

UNIVERSITY STANDARD. Title UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL STANDARD ON RAT AND MOUSE EUTHANASIA. Introduction

Beef Cattle Husbandry and Breeding

Bayer Environmental Science

SDS: Ofloxacin Ophthalmic Solution, USP 0.3%

LABELLING AND PACKAGE LEAFLET

LUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification. Telmisartan and Amlodipine Tablets 40 mg/5 mg; 40 mg/10 mg; 80 mg/5 mg and 80 mg/10 mg

Approving Investigator Managed Use Sites and Housing Areas SOP Number: PURPOSE: 2.0 SCOPE:

MATERIAL SAFETY DATA SHEET QUEEN GEL

UNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee

March 2013 Edition 1. Livestock Matters. A series of newsletters/bulletins to the farming community

Orientation to the Use of Laboratory Animals at Touro University--California

Bayer Environmental Science SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006

Giving IV Medication by Balloon System (EIS)

IOWA HIGH SCHOOL ATHLETIC ASSOCIATION REVIEW OF BLOOD-BORNE PATHOGEN PROCEDURES

Clean machine: your guide to brilliant practice hygiene

Safety Guidelines for Rearing and Experimentation of Laboratory Animals

NAME OF THE FACILITY: BY TICKING YES TO ANY RULE ON THIS CHECKLIST YOU AGREE THAT THE FACILITY ALREADY COMPLIES WITH THAT STANDARD.

Standard Operating Procedure (SOP) APPROVING INVESTIGATOR MANAGED USE SITES AND HOUSING AREAS

VOLUNTEER INFORMATION SHEET

Aide mémoire for environmental conditions and treatment of biological models

STREPTOMYCIN 17 FUNGICIDE COMMERCIAL. Wettable Powder READ THE LABEL BEFORE USING REGISTRATION NO PEST CONTROL PRODUCTS ACT

Disaster Sheltering. Module 3 - Small Animal Shelter Standard Operating Procedures (SOPs)

SAFETY DATA SHEETS. This SDS packet was issued with item:

AVIAN HUSBANDRY (POULTRY HATCHING AND CHICKS)

INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE ANIMAL PROTOCOL REVIEW QUESTIONNAIRE. Name Role on Protocol Department P. O.

The Authority for Biological and Biomedical Models (ABBM) The Hebrew University

SUMMARY OF PRODUCT CHARACTERISTICS

IACUC POLICIES, PROCEDURES, AND GUIDELINES

EXPERIMENT. Antibiotic Sensitivity-Kirby Bauer Diffusion Test

MSDS: Ofloxacin Ophthalmic Solution, USP, 0.3%

STANDARD OPERATING PROCEDURE RECEIVING, QUARANTINE, AND ACCLIMATION FOR SHORT TERM USE OF PURCHASED AND DONATED HORSES FOR TEACHING AND RESEARCH

Ubroseal Dry Cow 2.6 g intramammary suspension for cattle

Veterinary medicines. Prescriptions 2. Dispensing veterinary medicines 3. Storage of poisons and restricted substances 5

So Why All the Fuss About Hand Hygiene?

The legislation and handling poisons

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

The Guide for the Care and Use of Laboratory Animals, 8th Edition, November Euthanasia. pp

Animal Care Assistant Cats Animal Care Volunteer Training Manual

Continued animal holding beyond the year of certification constitutes Procedural Non-Compliance and will be treated as such.

STANDARD OPERATING PROCEDURE RECEIPT, QUARANTINE, ACCLIMATION, AND PREVENTIVE MEDICINE STANDARDS FOR DOGS

Topic The traits of offspring are determined by genetic instructions received from the mother and the father.


MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Date of Preparation: July 2017 VANQUISH ARGENTINE ANT BAIT

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA)

VETERINARY PROCEDURES FOR HANDLING RABIES SITUATIONS June 2017

Institutional Animal Care and Use Committee: Procedures. Office of Research Affairs Research Integrity and Compliance Responsible Conduct of Research

CAF009. All undergraduate, graduate students, and researchers performing survival surgery on animals.

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

Infection Control and Standard Precautions

DREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS

A laboratory-associated outbreak of Cryptosporidiosis: biosafety intervention and corrective actions

CyLence. Ready to Use. Pour-On Insecticide. For Control of Horn Flies, Chewing Lice and Sucking Lice on Beef and Dairy (including lactating) Cattle

SOP: Subcutaneous Injections in Swine

INCIDE 25 FLY KILLER SURFACE AND TOPICAL SPRAY AGRICULTURAL. Main Panel English: InCide 25 Fly Killer ml 3 INSECTICIDE

4-H CVA LEVEL I EXAM APPLICATION PLEASE PRINT. First Name: Last Name: Address: City State Postal Code: Phone:( ) Date of Application:

Hantavirus Hazards and Version: 1.0 Control Practice Creator: Safety Services

SUMMARY OF PRODUCT CHARACTERISTICS

CANINE PARVO VIRUS HEALTHY HINTS I S S U E 1 GET THE BEST FOR YOUR BEST FRIENDS!

Transcription:

Institutional Biosafety Committee Standard Operating Procedure (SOP) Tamoxifen Principal Investigator: Room & Building #: Department: Phone #: Date: Location(s) Covered by this SOP: Building Lab # Procedures Done Note: The Occupational Safety and Health Administration (OSHA) requires a written SOP for any work with Particularly Hazardous Substance (PHS) in laboratories. This SOP must be customized for each lab using Tamoxifen and/or Tamoxifen solution. Insert a copy (either hard or electronic) into your chemical hygiene plan. Research involving tamoxifen use (in vitro or animal studies) must be approved by the Institutional Biosafety Committee (IBC). In addition, any Animal Care and Use Protocol (ACUP) in which tamoxifen is proposed for use in animal studies must be approved by the Institutional Animal Care & Use Committee (IACUC). Note: This SOP must be reviewed on an annual basis or whenever changes are made to use and/or location. A. USE & PROCEDURE Use this section to describe the process or circumstances of use. IUPAC name/cas No: Common name Tamoxifen Concentration in commercial product per stock vial (e.g. mg/ml) 1

State purpose of drug use and brief description of experimental procedure: B. GENERAL INFORMATION All tamoxifen work must be conducted in a Type II ducted Biosafety Cabinet (BSC). Alternatively, a certified operating chemical fume hood can be used if approved by the IBC. For any work conducted outside of a ducted BSC or fume hood, a particle respirator type N95 must be used. Contact EHRS at 2-2520 to be fit tested. Individuals planning a family or are pregnant can contact EHRS to schedule counseling. All workers must meet the training requirements listed in the training section of this SOP prior to using any tamoxifen. C. POTENTIAL HAZARDS Tamoxifen is an off -white odorless solid crystalline powder with a melting point of 140-144 C. GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) LD50 Oral: 4100 mg/kg (rat) Carcinogenicity (Category 1B), H350 Reproductive toxicity (Category 1B), H360 Effects on or via lactation, H362 Consult your Safety Data Sheet (SDS) for additional information. D. PERSONAL PROTECTIVE EQUIPMENT (PPE) The level of skin and eye protection should be selected based on the potential for splashing and other forms of exposure. 2

Minimum potential for splash & exposure: o Double pair of chemical resistant gloves (Change gloves frequently and immediately replace with new gloves when gloves become contaminated). Nitrile o Protective clothing shall be worn to prevent any possibility of skin contact with Tamoxifen. Lab coats Closed toed shoes Long pants Long sleeved clothing o Safety glasses, goggles or face shields shall be worn during operations in which Tamoxifen might contact the eyes (e.g., through vapors or splashes of solution). Safety glasses with side shields or chemical splash goggles - Must meet ANSI/OSHA specifications. When using or transferring large quantities or when using in systems under pressure. o Chemical splash goggles - Must meet ANSI/OSHA specifications. o Particle respirator type N95 (if not working in a BSC or fume hood or if hood s sash is not in the down position. o Double pair of chemical resistant gloves (Immediately replace with new gloves when gloves become contaminated). Nitrile o Chemical resistant apron/smock/lab coat o Protective Clothing Impervious sleeves Closed-toed shoes NOTE: Personnel using respirators must be enrolled in the University s Respiratory Protection Program. INSERT ADDITIONAL PPE AS NECESSARY: 3

E. ENGINEERING CONTROLS All operations involving tamoxifen (powder, granules, and solution) must be conducted in a certified ducted Biological Safety Cabinet or a properly operating and certified chemical fume hood. If using tamoxifen powdered form outside of a fume hood or BSCs, a particle respirator type N95 must be worn. In order to wear a full-face particle respirator, one must be medically cleared, fit tested and trained. Contact EHRS at 2-2520 to schedule fit testing. Syringes used for tamoxifen injection should be safety engineered type (self-sheathing syringes, luer-lock syringes, etc.). Safety Shower and Emergency eyewash should be easily accessible within the immediate work environment in areas where Tamoxifen is used. The nearest safety shower station is located at : The nearest safety eyewash is located at : Laboratory rooms must be at negative pressure with respect to the corridors and external environment. Laboratory/Room doors must be kept closed at all times. INSERT ADDITIONAL ENGINEERING CONTROLS AS NECESSARY: The nearest safety shower station is located at (building and room no.) The nearest safety eyewash station is located at (building and room no.) 4

F. SPECIAL HANDLING PROCEDURES & STORAGE REQUIREMENTS Laboratory-specific written procedures are required for tamoxifen. Attach procedures to SOP. Keep container closed at all times. Open containers of tamoxifen should never be permitted. Once mixed into an aqueous solution, tamoxifen should then be transferred into a sealed bottle. This will prevent volatilization, spillage, and accidental contamination of the environment. Tamoxifen-containing chow (for small rodent users, see below for additional procedures) can be obtained from a commercial vendor. Store in a cool, dry, well-vented area away from incompatible substances. Use the smallest practical quantities for the experiment being performed. Transport tamoxifen-containing solutions or chow in secondary containment. All areas which use tamoxifen must have a chemo spill kit present. Additional Standard Operating Procedures for Use in Animals (Requires IACUCapproved ACUP): EHRS issued signage must be posted to the door of the room in which the tamoxifen administration to small rodents will be performed. The signage will remain on the door for the duration of the tamoxifen treatment plus 72 hours. Tamoxifen may be administered to (type of animal) via (route of administration) at (dose or dose range of drug in mg/kg animal) during a treatment time period of (give time period of treatment). Injection or gavage of small rodents with tamoxifen-containing solution or changing tamoxifen-containing chow must be performed in either a certified Class II-B Biosafety Cabinet (BSC) or a certified operating chemical fume hood within ULAR facilities (as specified in approved ACUP). EHRS issued signage must be posted to the door of animal holding room where the small rodents are treated with tamoxifen during the entire treatment period plus 72 hours. A procedure card with a yellow chemo drug label sticker is placed on the cage along with the following information: 1) Name of drug: e.g. tamoxifen, or tamoxifen citrate etc. +- 2) PI of Lab and primary contact name and number, 3) date(s) of i.p. injection/oral gavage/chow administration and 4) Special handling time period (the entire period for injection/oral administration/chow feeding plus 3 days). Procedure card and biohazard information should be clearly visible on cage. 5

After administration of tamoxifen-containing solution or chow, all surfaces must be decontaminated immediately (as outlined in the Decontamination Procedures section below). All contaminated disposable materials should be disposed of in appropriate designated hazardous drug waste containers as outlined in the waste disposal section below. Yellow sharps containers for sharps and yellow bags for solid waste are available in all ULAR animal suites). For 72 hours following the last dose of intraperitoneal/oral administration of tamoxifen or replacement of tamoxifen-containing chow with normal chow (also known as the High Risk Period), ULAR animal technicians should avoid handling all Tamoxifen-marked cages until study completion and the removal of labeling. Only PI/trained staff should handle tamoxifen-treated animals and cages during this High Risk Period. If necessary, before 72 hours has passed since the final tamoxifen administration, the cages must only be opened in either a certified Class II BSC hood or a certified operating chemical fume hood within ULAR facilities. All dirty bedding, unused tamoxifencontaining chow (if applicable), etc. are disposed of in yellow bags as outlined in the Waste Disposal section below. All cage materials possibly contaminated with tamoxifen, including diet trays and wire bar lids, will be wiped down by EHRS-trained PI/lab staff with detergent solution before transferring these to the Chemo Rack for disinfected soiled cages. Note: Tamoxifen metabolism is hepatic, with excretion of metabolites largely restricted to the feces. Metabolite excretion continues for 3 days postadministration; therefore, care must be taken in the disposal of dirty bedding for 3 days after final administration or removal of tamoxifen-containing chow (High Risk Period). After this High Risk Period is completed, PI should move the animals to clean cages, after which no special handling of the bedding, cages or animals is required and procedure cards may be removed. INSERT ADDITIONAL HANDLING & STORAGE REQUIREMENTS AS NECESSARY: 6

G. TRAINING REQUIREMENTS All personnel are required to complete the EHRS hazardous drugs safety training prior to working with any OSHA-defined hazardous drugs. The Principal Investigator (PI) must provide lab specific training to all laboratory workers specific to the hazards (physical and health) involved in working with the substance, work area decontamination and emergency procedures. In addition, the PI must review and provide a copy of the SDS and this SOP to any lab worker prior to working with any of the materials covered by this SOP. The PI must ensure that all lab personnel have attended all the required safety training and/or refresher training. Personnel working with small rodents are required to complete IACUC mandated trainings. Staff working in Main Campus who are responsible for packing the chemo and biohazard waste and who must sign the waste manifest presented by Stericycle prior to shipment must complete the required EHRS Shipment of Dangerous Goods training. H. DESIGNATED AREAS Designated area(s) for use and storage of tamoxifen must be established. This may be specific work benches, BSCs or chemical fume hoods. All chemicals must be in secondary containment with proper signage. (For animal areas only) EHRS issued signage is required for the container, designated work area and storage locations. Signage must follow the Safety Data Sheet (SDS) and GHS Classification 29CFR1910 (OSHA). Access to the designated areas shall be limited to trained and knowledgeable personnel. INSERT LOCATION OF DESIGNATED AREA(S): Tamoxifen storage area is located at: (building and room number) I. SPILL PROCEDURES Spills-General Instructions o Notify others of the spill and keep spill area confined. o Review SDS. o Don appropriate PPE (double nitrile gloves, splash goggles, face shield and lab coat). o Extinguish all ignition sources. 7

o Collect all spilled material and clean up material and place into an appropriate waste container or double lined bag yellow bag containing chemo waste markings. Label the waste container with a chemotherapeutic waste label. o Call EHRS at 215-707-2520 during office hours to report the spill. o Call Page operator at 215-707-4545 after office hours to report the spill. Minor Spills-Liquid o Neutralize and/or absorb freestanding liquid with absorbent included in a chemo spill kit, vermiculite, sand, etc. and absorbent pads. o Place clean up items in chemo waste container double lined with yellow plastic bag with chemo waste markings. o Wait 10 minutes and wash spill area with soap and water. Minor Spills-Solid o Wet paper towels or absorbent pads and gently place on top of the powder to avoid creation of dust. o Carefully wipe up the area and place clean up material into an appropriate waste container or double lined bag. Label the bag/container with contents. o Wait 10 minutes and wash spill area with soap and water. Major Spills-Liquid & Solid o Evacuate room or immediate area. o Call EHRS at 215-707-2520. o Post signs at entrances/exits notifying others of spill. o Provide assistance and information to spill responders. INSERT LOCATION OF TAMOXIFEN SPILL KIT: o The chemotherapeutic drug spill kit is located at (building and room number) J. FIRST AID/EXPOSURES General Instructions o Obtain SDS. o Contact Campus Police at 215-204-1234 if immediate medical assistance is necessary. o Notify Supervisor. o Notify EHRS at 215-707-2520 during office hours and the Page operator at 215-707-4545 after office hours. o Seek medical assistance after any accidental exposure. Inhalation o Remove exposed individual to fresh air. o Seek medical attention. 8

Skin/Body Contact o Remove clothing and rinse body in emergency shower for at least 15 minutes. o Seek medical attention. Eye Contact o Immediately rinse eyeball and inner surface of eyelid for at least 15 minutes. o Seek medical attention. Ingestion o Seek immediate medical attention. INSERT LOCATION OF NEAREST STUDENT HEALTH, EMPLOYEE HEALTH AND HOSPITAL Main Campus 1. Employee Health Services, 1810 Liacouras Walk, fourth floor, M-F, 8:00 am 12pm; 1:00 pm - 5:00 pm. Phone: 215-204-2679. 2. Student Health Services, 1810 Liacouras Walk, fourth floor, Mon, Tue, Thurs, Fri, 8:30 am - 5:00 pm, Wed, 10:00 am 5:00 pm, Phone: 215-204-7500. 3. After hours: Emergency Department at Temple University Hospital, 3401 N. Broad Street, Philadelphia, PA 19140. Health Science Center 1. Occupational Health Department at Temple Hospital, Basement of Rock Pavilion M-F, 8:00 am - 5:00 pm, Phone: 215-707-4455 2. Student Health Services, Student Faculty Center, Lower Basement, Room 43, M-F, 8:30 am - 4:30 pm, Phone: 215-707-4088. 3. After hours: Emergency Department at Temple University Hospital, 3401 N. Broad Street, Philadelphia, PA 19140. K. DECONTAMINATION PROCEDURES All work areas, lab benches, equipment (glove boxes, hoods) and glassware where tamoxifen is prepared and/or administered should be cleaned immediately following each task completion utilizing a detergent/water solution. 9

INSERT ADDITIONAL DECONTAMINATION PROCEDURES: L. WASTE DISPOSAL Tamoxifen solutions and powders must be disposed of only through EHRS. Syringes and needles used for tamoxifen injection should be disposed of in approved chemo sharps containers, Needles should never be bent, sheared, or recapped. Chemo sharps must be segregated from sharps contaminated with infectious materials. Use a chemo waste sticker to properly label each yellow bag or sharps container. Properly labeled tamoxifen-contaminated solid waste and sharps are picked up by trained Housekeeping staff for off-site disposal (if generated at the HSC campus) and by Stericycle (if generated at Main Campus). Carcasses euthanized or otherwise suspected to be contaminated with tamoxifen must be disposed of as chemotherapeutic waste up to 72 hours following the last tamoxifen treatment. The carcasses must be disposed of at the designated chemo waste freezer at ULAR facility at MERB 571 (Health Science Campus) or at Weiss Hall Room (list location of chemo animal freezer). Any solid waste and animal bedding collected after 72 hours post the last tamoxifen treatment may be disposed of as regulated medical waste. Carcasses generated after 72 hours post the last tamoxifen treatment may be disposed of as regulated medical waste (RMW) at the designated infectious waste freezer at ULAR facility. Note: Tamoxifen metabolism is hepatic, with excretion of metabolites largely restricted to the feces. Metabolite excretion continues for 2 days post-administration; therefore, care must be taken in the disposal of dirty bedding for 72 hours after the last administration. 10

INSERT ADDITIONAL WASTE DISPOSAL: 1. The tamoxifen-soiled food/bedding, procedural wastes are to be disposed of as chemotherapeutic waste during the entire treatment plus 72 hours. 2. The lab members don proper PPE (gloves, mask, hair cover, shoe covers, disposable gown) when performing chemo waste disposal (for example cage change). 3. The soiled cage containing food and bedding that need to be changed will be transferred to a cage change station. The cage change location is located at. Micro-isolator is to be changed once every two weeks. Regular cage is to be changed once every week. 4. The lid of the soiled cages should be opened inside a cage change station. 5. The food and bedding should be disposed of into a yellow chemotherapeutic waste bag inside a cage changing station. ULAR operation will provide the yellow chemotherapeutic waste bag. The PI is responsible for purchasing the reusable yellow solid waste container (one time only). 6. Once the yellow bag is 2/3 full, the bag should be securely sealed either by taping or tying a knot. 7. A chemotherapeutic waste stick-on label should be placed on each yellow bag with the information completed (generator name, contents, phone number, date). EHRS or ULAR operation can provide the label. 8. The soiled cages will be disinfected by thoroughly wiping down with detergent solution before lab worker transfers these to the Chemo Rack for disinfected soiled cages. 9. The Chemo Rack for the yellow bag disposal is located as follows: If housing the animals at the MERB 5 th floor, the yellow bags are to be placed near the entrance of MERB 580 from the clean side of the facility. 11

If housing the animals at MERB 6 th floor, the yellow bags are carried via the outer suite service elevator to the MERB 5 th floor, turn left from the corridor and place the yellow bags at the Chemo Rack near the entrance of MERB 580 from the dirty side of the facility. If housing the animals at PAH 6 th floor, the yellow bags are to be placed directly in PAH 611 (soiled side entrance). If housing the animals at Weiss Hall 10 th floor, the yellow bags are to be placed directly in Room (list room number). 10. The Chemo Rack for disinfected soiled cages to be cleaned are located as follows: If housing the animals at the MERB 5 th floor, the soiled cages are to be placed in the Soiled Cage Rack at the hallway of MERB 580 from the clean side of the facility. If housing the animals at the MERB 6 th floor, the soiled cages are to be transported via the outer suite service elevator to the MERB 5 th floor, when entering the MERB 5 th floor, turn left from the corridor and place the cages at the Chemo Rack near the entrance of MERB 580 from the dirty side of the facility. If housing the animals at the PAH 6 th floor, the soiled cages are to be placed directly in PAH 611 (soiled side entrance) If housing the animals at Weiss Hall 10 th floor, the soiled cages are to be placed directly in Room (list Soiled Cage Location). The soiled cages are stored at the Soiled Cage Rack for 72 hours before tunnel wash. After the last treatment of tamoxifen plus 72 hours, all the bedding and food may be disposed of as red bag waste (biohazard). The ULAR staff will perform soiled cage change based on ULAR SOP. ENTER TRAINING HISTORY ON NEXT PAGE 12

DATE OF TRAINING (lab workers and animal care providers Name (please print) Signature TU ID Number Department Position/Title PRINCIPAL INVESTIGATOR CERTIFICATION I certify that I have read and understand the requirements of this Standard Operating Procedure (SOP) and that I agree to fully adhere to its requirements. Principal Investigator Signature: Title: Date: 13